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Objectives: The purpose of this study was to analyze the trends in cartilage repair strategies among
Turkish orthopedic surgeons for isolated focal (osteo)chondral lesions of the knee joint.
Materials and methods: Aweb-based survey of 21 questions consisting of surgical indications, techniques
and time to return to sports was developed to investigate the preferences of members of the TOTBID and
the TUSYAD.
Results: A total of 147 surgeons answered the questionnaire.70% of the respondents were TUSYAD
members. 82% of respondents had at least ﬁve years experience in arthroscopy. Half of the surgeons
indicated that patient age of 50 was the upper limit for cartilage repair. Irrespective of activity level,
microfracture (60e67%) was the most frequently used technique for lesions smaller 2.5 cm2. In lesions
larger than 4 cm2, MACI was the most commonly advocated procedure (67%). In patients with high
activity levels, mosaicplasty was the ﬁrst choice (69%) for lesions between 2.5 and 4 cm2 in size, followed
by MACI (27%).
Conclusion: Patient age, activity level, BMI and lesion size were important determinants for the choice of
treatment of isolated chondral lesions in the knee. These results reﬂect the choices of experienced knee
surgeons in the country. Although not widely performed in Turkey and has limited reimbursement by the
health care system, the ﬁrst choice for defects over 4 cm2 was second generation ACI. Third party payers
& health reimbursement authorities should take into account that large defects require methods which
are relatively expensive and need high technology. Cross-sectional survey, Level II.
© 2016 Turkish Association of Orthopaedics and Traumatology. Publishing services by Elsevier B.V. This is
an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
4.0/).Introduction
Injuries to the articular cartilage of the knee are common. Due to
its inherent lack of vascular supply and limited intrinsic regenera-
tion capacity of articular cartilage, untreated cartilage defects may
lead to early onset osteoarthritis. The management of symptomatic
focal traumatic articular cartilage lesions of the knee in active in-
dividuals remains a substantial challenge. Although a variety of
methods have the potential to stimulate the formation of a new
articular surface, none of the current techniques includingciation of Orthopaedics and
s and Traumatology. Publishing semicrofracture, autologous or allogenic osteochondral grafts, autol-
ogous chondrocyte implantation (ACI), growth factors and scaffolds
are able to replicate the original anatomy and architecture of hya-
line cartilage.1,2 Choosing the best technique that addresses the
individual defect is a challenge for the orthopedic surgeon. Smaller
defects not affecting the subchondral bone are usually treated with
microfracturing while lesions with loss of subchondral bone can be
managed with autologous osteochondral autograft transfer (OAT)
ie. mosaicplasty. Defects larger than 2.5 cm2, can still be managed
with microfracture and OAT however, their limited effectiveness in
larger lesions has led the search for advanced cartilage repair
strategies such as matrix-assisted chondrocyte implantation
(MACI).
There is no universally accepted algorithm for treatment of
cartilage defects and the treatment preferences of Turkishrvices by Elsevier B.V. This is an open access article under the CC BY-NC-ND license
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analyze the treatment preferences of Turkish orthopedic surgeons
for different types of cartilage defects and to potentially highlight
treatment recommendations.
Material and methods
A 21-item electronic questionnaire prepared by the members of
the TUSYAD Cartilage Committee was designed to collect data on
indications for surgery, patient characteristics (including patient
age, BMI, activity level) and treatment options to evaluate the
cartilage repair practice patterns of Turkish orthopedic surgeons
(Table 1 shows ﬁrst 16 questions). This survey was performed on
Turkish Society of Orthopedics & Traumatology (TOTBID) and
Turkish Society of Sports Injuries, Arthroscopy & Knee Surgery
(TUSYAD) members. The survey was completed via the web using
Survey Monkey (http://www.surveymonkey.com). The ICRS (In-
ternational Cartilage Repair Society) Classiﬁcation for focal cartilage
lesion was used to deﬁne cartilage defects.3
Results
Surgeon demographics
A total of 147 surgeon members of TOTBID ﬁlled out the ques-
tionnaire. Ninety eight (70%) of the responders were also members
of TUSYAD. Approximately 1/3 of the respondents practiced in a
private hospital, 1/3 in a university clinic, 15% in a state hospital and
13% in a state teaching and research hospital. Seventy nine percent
of the respondents performed knee arthroscopy as the most
frequent procedure. This was followed by arthroplasty (48%) &
trauma surgery (42%). Most of the surgeons had more than 5 years
experience in knee surgery and performed more than 50 arthro-
scopic procedures per year. The majority of the surgeons treated
cartilage defects in the knee and ankle joints arthroscopically,
arthroscopic treatment of shoulder cartilage defects were less
frequent (Table 2).
Conservative treatment
The most common non-surgical treatment offered by the re-
spondents were intra-articular hyaluronic acid injections (80%) and
physiotherapy (75%). This was followed by lifestyle changes (70%),
systemic pain medication (65%), oral glucosamine (60%) and
platelet rich plasma injections (41%). The rate of surgeons using
steroid injections was only 5,6% (Fig. 1).
Surgical treatment
The upper age limit for cartilage surgery was reported as 50
years by 52%, 40 years by 25% of the surgeons and 60 years by 12%.
Obesity was also an important factor in deciding surgical treatment.
The upper limit of body mass index (BMI)was accepted as 30 kg/m2
by 58% and 25 kg/m2 by 22% of the respondents. Location of the
cartilage defect had a signiﬁcant effect on the outcome. The best
results were obtained in the lesions of the femoral condyles (85% of
the surgeons). The most commonly performed cartilage procedure
was microfracture (60e80%) followed by mosaicplasty (20e40%).
MACI was utilized by less than 10% of the surgeons. A third of the
surgeons performing microfracture accepted the upper age limit as
50. Seventeen percent lowered this limit to 45 while twenty-three
percent of the surgeons thought that age was not an important
factor (Fig. 2). Microfracture was performed using a dedicated in-
strument by 81% of the surgeons. More than half of the surgeons
(58%) did not use a continuous passive motion device (CPM) aftersurgery. The most common usage was reported to be 2 h/day in the
ﬁrst week for respondents who used a CPM device (27%). Partial
weight bearing after microfracture was allowed in 4 weeks by 23%
of the surgeons, while for 22% this time period extended to 6weeks.
Twenty ﬁve percent of the respondents allowed full weight bearing
on the 6th post-operative week. Time to return to sports following
cartilage repair was advocated at 6 months for microfracture (86%),
9 months for mosaicplasty (63%), and 12 months for MACI (73%)
(18 question).
Lesion size & depth
In patients with high activity levels, ICRS grade 3e4 lesions
smaller than 2.5 cm2, were most frequently treated with micro-
fracture (60%) followed by mosaicplasty (40%). For mid-size lesions
between 2.5 and 4 cm2, mosaicplasty was the ﬁrst option (%69),
followed by MACI (%27). In lesions larger than 4 cm2, MACI was the
most commonly advocated procedure (%67). Ninety percent of the
surgeons had never used scaffold augmented microfracture but 17%
would consider its use in active patients under 45 years of age
(Fig. 3). In patients with low activity levels, ICRS grade 3e4 lesions
smaller than 2.5 cm2 were most frequently treated with micro-
fracture (67%) followed by mosaicplasty (23%). For mid-size lesions
between 2.5 and 4 cm2, microfracture was still the ﬁrst option in
54% followed by mosaicplasty in %69. In lesions larger than 4 cm2,
MACI was the most commonly advocated procedure (%38), fol-
lowed by mosaicplasty in 30% and microfracture in 28% (Fig. 4).
Fifty percent of the surgeons would not offer surgical treatment for
symptomatic ICRS grade 1e2 lesions smaller than 1 cm2 but would
consider surgery in larger lesions. The preferred operative treat-
ment of ICRS grade 1e2 lesions between 1 and 4 cm2 was
debridement in 53%, antegrade or retrograde drilling was the sec-
ond choice. For cartilage lesions involving the subchondral bone,
42.4% of the surgeons would address both bone and cartilage de-
fects. This would involve a one stage operation in 25.4% while a two
stage operation would be advised in a signiﬁcantly less number of
cases (7.6%). Only 13% of the surgeons would prefer microfracturing
to treat such lesions, while a total of 28.8% would utilize either an
osteochondral plug or bone graftingþ ACI depending on lesion size.
Discussion
Several important trends have emerged from the ﬁndings of this
study. Mosaicplasty or ACI was the ﬁrst choice in high activity pa-
tients for mid sized (2,5e4 cm2) defects. This may be due to the
progressive deterioration of the outcomes of microfracture over the
years and implies the need for a more durable treatment in these
cases. Although limitations for reimbursement & cost are impor-
tant issues, MACI was the ﬁrst choice for larger defects (over 4 cm2).
Third party payers & health authorities should consider this need
for advanced cartilage regeneration techniques and should imple-
ment the necessary regulations and reimbursement systems to
make these treatments available to orthopedic surgeons. It is
interesting to note that, although cell free scaffolds were available,
90% of the surgeons had never used this technique at the time of
the study. This may be explained by the limited evidence for the
efﬁcacy of these cell free implants.
Despite the fact that there have been a variety of methods for
cartilage repair, to date, no universally accepted treatment guide-
lines concerning patient age, lesion size, depth (chondral/osteo-
chondral), rehabilitation or return to sports exist.4 Unfortunately,
no clear recommendations have emerged from well designed,
randomized-controlled trials for the treatment of focal cartilage
defects.5e8 The aim of this survey was to analyze the preferences
for treatment of focal knee cartilage defects among a community of
Table 1
First 16 questions of the survey.
1. I am a member of Orthopaedic and Traumatology society❑ TOTB_ID
❑ TUSYAD
9. I get the best results in lesions located in the❑ Femoral condyle
❑ Trochlea
❑ Patella
2. I work at a❑ State Hospital
❑ Training and Research Hospital
❑ University Hospital
❑ Private Hospital
❑ Private practice
10. For nonoperative treatment of cartilage lesions I employ the following techniques❑ Non weight bearing
❑ Physiotherapy
❑ Oral Glucosamines
❑ Intraarticular hyaluronic acid
❑ Intraarticular steroid
❑ Platelet rich plasma (PRP)
❑ Analgesics
❑ Change of lifestyle
❑ Other
3. The most common surgical procedures in my practice are❑ Arthroplasty
❑ Trauma
❑ Arthroscopy-knee surgery
❑ Foot and ankle surgery
❑ Upper extremity surgery
❑ General orthopaedics
11. In cases of subchondral bone deﬁciency I❑ Always try to treat cartilage and bone
❑ Usually try to treat in one surgical setting
❑ Usually treat with a two stage operation
❑ Only perform microfracture
❑ Only perform OATS
❑ Perform OATS or MACI, depending on defect size
4. I treat cartilage lesions in the following joints❑ Knee
❑ Ankle
❑ Shoulder
❑ Elbow
❑ Hip
12. When performing microfracture I set the upper age limit as❑ <30 years
❑ <40 years
❑ <45 years
❑ <50 years
❑ <60 years
❑ Age is not important
5. My experience in knee surgery❑ 1 year
❑ 1e5 year
❑ 5e10 year
❑ 10e20 year
❑ >20 year
13. I use for microfracture procedure❑ K-wire
❑ Drill bit
❑ Microfracture instrument
6. I perform knee arthroscopies per year❑ <50
❑ 50e100
❑ 100e200
❑ 200e500
❑ >500
14. I begin weight bearing after microfracture❑ Immediately
❑ 2. week
❑ 4. week
❑ 6. week
7. When performing cartilage repair I set my maximum patient age as❑ <30
❑ <40
❑ <50
❑ <60
❑ No age limit
15. I use continuous passive motion device after microfracture❑ Never
❑ First week two hours/day
❑ First week six hours/day
❑ First six weeks two hours/day
❑ First six weeks six hours/day
8. When performing cartilage repair I set maximum patient BMI (body mass index)
as❑ < 25 kg m2
❑ < 30 kg m2
❑ < 35 kg m2
❑ BMI is not important
16. I perform scaffold augmented microfracture❑ Never
❑ Below 45 years, patients with high activity level
❑ Always regardless of age
❑ Always regardless activity level
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Table 2
Breakdown of surgeon demographics.
Year of practice in knee surgery Percentage (%)
0e5 years 16
6e10 years 22
11e20 years 39
21 (þ) years 21
Number of arthroscopies per year
50 () 20
51e100 40
101e200 24
201 (þ) 17
Joints treated arthroscopically
Knee 87
Ankle 67
Shoulder 18
All 3 joints 12
Fig. 1. Rate of non-surgical treatment modalities employed by the respondents.
Fig. 2. For microfracture, the upper age limit accepted by surgeons.
Fig. 3. Treatment preferences for athletes with high activity levels who have a
symptomatic cartilage lesion (Answers for question 19).
Fig. 4. Treatment preferences for athletes with low activity level who have symp-
tomatic cartilage lesion (Answers for question 20).
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reﬂect the preferences of experienced and active knee surgeons in
the country as 84% had been in practice more than 5 years. 80%
performed more than 50 arthroscopic procedures per year. This
survey of experienced surgeons may help to identify the most
appropriate and current treatment methods until studies with
higher levels of evidence can be performed.
Numerous agents for the conservative treatment of chondral
lesions and early osteoarthritis.9e11 In this survey, the most
frequently used conservative measures were intra-articular hyal-
uronic acid injections and physiotherapy. These were followed by
lifestyle changes and systemic pain medication and glucosamine/
chondroitin sulfate supplements. Less than half of the surgeonsused platelet rich plasma injections despite the hype and media
pressure surrounding its use. Although preliminary studies
describe symptomatic beneﬁt of PRP injections for a limited time
period; more studies are needed to clarify the role of different
methods of production, PRP characteristics, presence and absence
of leukocytes, clinical indications, way of administration and ther-
apeutic protocols.12 Although widely used by the rheumatologists,
the ratio of surgeons who used steroid injections was only 5,6%.
This may be due to its limited and short term beneﬁt on pain and
function.11
Various surgical techniques, both reparative and regenerative,
have been used to treat focal (osteo) chondral pathology.13e15 Since
Steadman ﬁrst described its use in the 1980s, microfracture has
become popular as a ﬁrst-line treatment for chondral injuries.16,17
The clinical outcome seems dependent on the patient's age, level
of activity, defect location and postoperative regimen.16,17 The un-
derlying principle of the microfracture technique is bone marrow
stimulation and penetration of the subchondral bone plate result-
ing in the recruitment of mesenchymal stem cells which eventually
differentiate into ﬁbrocartilage.5,6,17e26 Although the initial results
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erate is mainly composed of ﬁbrocartilage and the results begin to
deteriorate over time after 4e5 years.5,6,24,26 In our survey, micro-
fracture was found to be the most common cartilage repair pro-
cedure (60e80%) followed by mosaicplasty in 20e40%. MACI was
performed by less than 10% of the surgeons. Many studies have
shown that younger age and smaller lesions results in better out-
comes following microfracture.5,6,17e26 While microfracture gives
best results in patients under the age of 40 years, an upper age limit
beyond which microfracture confers little or no beneﬁt has not
been established. In this survey, 23% of surgeons indicated that they
had no upper age limit for performing microfracture, while 34%
indicated an upper age limit of 50 years. This over utilization of
microfracture may be due to the limited availability of other
cartilage repair techniques due to reimbursement and regulatory
issues. In patients with high activity level, lesions smaller than
2.5 cm2, were most frequently treated with microfracture followed
bymosaicplasty. This was reversed for mid size lesions between 2.5
and 4 cm2 where mosaicplasty was the treatment of choice.
Mosaicplasty is perceived as a more durable solution that achieves
a covering of hyaline cartilage in these active patients. Comparative
studies have shown higher activity levels and better clinical results
after mosaicplasty compared to microfracture.18,27 However the
utilization of mosaicplasty is limited by the size of the donor area.
Donor site symptoms, although reported to be less than 5%, are also
an important issue.28 This has led to search for alternative solutions
in larger defects over 4 cm2. MACI has is an attractive option in
these cases as the technique is not limited by the size and shape of
the defect.22,24,29,30 Regulatory and reimbursement issues, the need
for two stage surgery and expense are the main issues preventing
widespread use of MACI. The ﬁrst choice for large defects was MACI
in this survey although less than 10% of the surgeons had per-
formed the technique. This underscores the demand for advanced
cartilage repair techniques in these rare but potentially debilitating
cartilage lesions. The current regulations in Turkey severely limit
the use of MACI and reimbursement is only possible in a select
group of hospitals after pre-approval of the Ministry of Health.
Third party payers still consider MACI as an experimental proced-
ure although the technique has been in use for more than two
decades and its efﬁcacy has been demonstrated in over 20.000
patients treated with either 1st generation ACI or MACI.29,30 Third
party payers should be aware of the need for advanced (albeit
expensive) technologies for larger chondral defects. Microfracture
was the most commonly preferred technique in small and mid-
sized lesions in patients with low activity levels. MACI (48%) was
the ﬁrst choice in larger defects, although mosaicplasty (30%) &
microfracture (25%) were also considered.
In our survey, body mass index (BMI) was considered an
important factor in decision making by 84% of the respondents. The
upper limit of cartilage regeneration surgery was stated as below
30 kg/m2 by 58%. A BMI larger than 30 kg/m2 has been correlated
with an inferior outcome after microfracture and cartilage pro-
cedures.17,20 Hence, it would certainly seem logical to establish a
BMI value beyond which microfracture should not be attempted.
The postoperative regimen after microfracture remains one of
the most debated issues regarding this technique. CPM has been
shown to improve the quality of regenerated cartilage in the
experimental setting.31 However, no randomized, controlled
studies have studied the beneﬁcial effects of CPM in humans after
microfracture.17,18,21,25 In our survey, more than half of the re-
spondents did not use CPM in the rehabilitation phase. This might
be due to constraints of expense and availability of home CPM
devices. Those who used CPM after surgery most frequently rec-
ommended 2 h per day in the ﬁrst weeks. The recommended 6
weeks therapy could not be completed for most of the cases, thisagain is probably due to logistical problems and expense. Weight
bearing after microfracture is another debated issue. The survey
questions did not specify the size or location of the lesion, therefore
a variety of answers were obtained. Partial weight bearing was
allowed at 2 weeks by 13%, 4 weeks by 23%, 6 weeks by 22% of the
respondents. Similarly full weight bearing was allowed at 2 weeks
6%, 4 weeks 9%, 6 weeks by 25% of the respondents. This indicates
that the respondents adopted a conservative and restricted weight
bearing regimen after surgery. Return to active sports following
cartilage repair was accepted at 6 months for microfracture (86%), 9
months for mosaicplasty (63%), and 12months for MACI (73%). This
is in contrast to several studies in the literature which have found
earlier return to sports after mosaicplasty compared to micro-
fracture.18,27,32 The late return to sports after ACI is expected as
these are complex cases and the desire of the surgeons to wait for
maturation of the regenerate.
Although 90% of surgeons had never use the matrix-supported
microfracture method, 17% considered that it could be a choice
for individuals with a high activity level and younger than 45 years.
This underscores the need for newer and innovative techniques
based on the unsatisfactory results of microfracture.
In conclusion, this study gives important information on the
trends of cartilage repair of Turkish orthopedic surgeons. Third
party payers should take into account the need for advanced and
probably more expensive cartilage repair technologies since cur-
rent techniques have unsatisfactory outcomes in larger lesions and
younger active patients.References
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